Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,617.10 -329.83 (-0.85%) Hang Seng
19,195.60 -25.02 (-0.13%) FTSE 100
8,388.78 -27.67 (-0.33%) Bitcoin USD
69,907.48 -1,109.15 (-1.56%) CMC Crypto 200
1,474.92 -51.49 (-3.37%)
iCAD, Inc. (ICAD)
After hours:
| Previous close | 1.6400 |
| Open | 1.6100 |
| Bid | 1.6000 x 100 |
| Ask | 1.6500 x 100 |
| Day's range | 1.5800 - 1.6800 |
| 52-week range | 1.1400 - 3.9700 |
| Volume | |
| Avg. volume | 201,154 |
| Market cap | 43.26M |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2700 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.83 |
- GuruFocus.com
icad Inc (ICAD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth and Operational ...
Discover how icad Inc achieved a 14% revenue increase and improved operational metrics in the first quarter of 2024.
GlobeNewswireiCAD Reports Financial Results for First Quarter Ended March 31, 2024
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.0 million, up 10%Total revenues were $5.0 million, up 14%Gross Profit Margin % was 83%, up from 82%GAAP Net Loss from
- GlobeNewswire
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
Call Time is 8:30 AM Eastern TimeNASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at 8:30 AM Eastern Time on Wednesday, May 15, 2024. Earnings call details are as follows: Domestic: 877-545-0523International: 973-528-0016Participant Access Code: 730845Webcast: https:
